US Equities
Is bluebird bio Inc. (BLUE) edging towards a correction?
A biotechnology company called Bluebird bio Inc. (BLUE) has dropped about 30% of its value since the start of 2021. Because of gene therapy trials that have failed over time, investors have been leery of these stocks. However, other developments in bluebird bio’s portfolio are
